{"name":"Cyberonics, Inc.","slug":"cyberonics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":282014160,"revenueGrowth":10.9,"grossMargin":0,"rdSpend":43284432,"netIncome":57847534,"cash":315944195,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2014"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Anti-Epileptic Drug (AED)","genericName":"Anti-Epileptic Drug (AED)","slug":"anti-epileptic-drug-aed","indication":"Adjunctive therapy for refractory partial-onset seizures in patients ≥4 years old","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Best Medical Practive","genericName":"Best Medical Practive","slug":"best-medical-practive","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Anti-Epileptic Drug (AED)","genericName":"Anti-Epileptic Drug (AED)","slug":"anti-epileptic-drug-aed","phase":"marketed","mechanism":"Vagus nerve stimulation (VNS) delivers electrical pulses to the vagus nerve to modulate brain activity and reduce seizure frequency.","indications":["Adjunctive therapy for refractory partial-onset seizures in patients ≥4 years old","Adjunctive therapy for generalized seizures"],"catalyst":""},{"name":"Best Medical Practive","genericName":"Best Medical Practive","slug":"best-medical-practive","phase":"marketed","mechanism":"This appears to be a reference to best medical practice guidelines rather than a specific pharmaceutical drug product.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE9GX0g0cFRSS1VHYklxQnNYWTQyZk9TOGNOV21pZmt6RWdfSk1Rbm9FZUFpbEFsRlpyeDVDVno5T09TRDFsQWVUY2NsTzNBM1BLNnpRRUc0NDRjNlRkQWlTMkluZVpqZw?oc=5","date":"2024-07-22","type":"pipeline","source":"Psychiatry Online","summary":"Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report - Psychiatry Online","headline":"Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxPMGxoM3lNWTNlMVNvdElYZ3ZFazM3R19UOExPU1Y0OWJCZmxia2VTSjFsb2VGQ2dtdWtDYlBYaWJzTDZnaF9BSUVzU1Rub29KU3VtaGk2UDJDS0t6UVo5XzdGTUFFMXZGbmNOZDZST015dU1QYTl0TzlxTjRubDFKVFlWZHVxd0hvemJiOG42TVdyTHpicmFfSTJrTWdfX1l2dUdOS19nejJwMmtSVFNXVUlKbEJDcXlDR2JXQVNEOVF2eV9ZcGNFdlQ0eEF4amEwMjh1Z3JwQWQ0NEc4?oc=5","date":"2014-11-19","type":"pipeline","source":"BioSpace","summary":"Cyberonics Inc. Release: Epilepsy Patients And Advocates Urged To Deck Their Halls With Purple Lights This Holiday Season - BioSpace","headline":"Cyberonics Inc. Release: Epilepsy Patients And Advocates Urged To Deck Their Halls With Purple Lights This Holiday Seaso","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE5rTlhCY2RkR1NxbmVhUmcxa0lvMkpLRUhSMWV2SWlNSnU2MHpwN0F6Vlh3WTgwNkRhQ0Uyb0ZzaGdsQm9NOHNQVVJuUEQxaFpPeTB4NjdwUFphTG9UdzFTTlphbjlELTNvbzZRaXlDRQ?oc=5","date":"2014-03-27","type":"pipeline","source":"Orthopedics This Week","summary":"Matricaria Assumes Orthofix Chair - Orthopedics This Week","headline":"Matricaria Assumes Orthofix Chair","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5hSTlfNFNXaUhCNWplcDlyM2w2UlhsNU5fQVczLXI5VGtIdUdyN2ZLMDJJSUFJQi0wNGphcHRIWm5fdXUtMllwcEJWMHJMTlNlVk44?oc=5","date":"2008-06-04","type":"trial","source":"Nature","summary":"A PET Study of Tiagabine Treatment Implicates Ventral Medial Prefrontal Cortex in Generalized Social Anxiety Disorder - Nature","headline":"A PET Study of Tiagabine Treatment Implicates Ventral Medial Prefrontal Cortex in Generalized Social Anxiety Disorder","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1IVDNOUDNPcTl4TjhyOHZKV25JamdRVkJ4ckRPVXF1dDU2MUtSM3F3REh0VUUwY28zZzcxWnIxbTIwTGR2N1ZCZ1FHVExhYkR2SVlR?oc=5","date":"2008-04-16","type":"pipeline","source":"Nature","summary":"Estimates of Serotonin and Norepinephrine Transporter Inhibition in Depressed Patients Treated with Paroxetine or Venlafaxine - Nature","headline":"Estimates of Serotonin and Norepinephrine Transporter Inhibition in Depressed Patients Treated with Paroxetine or Venlaf","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":282014160,"revenuePeriod":"2014-04-25","revenueHistory":[{"value":282014160,"period":"2014-04-25"},{"value":254320417,"period":"2013-04-26"},{"value":254320417,"period":"2013-04-26"},{"value":218502731,"period":"2012-04-27"},{"value":218502731,"period":"2012-04-27"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":43284432,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":57847534,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":315944195,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}